Biotechnology Industry Organization (BIO) news
The Biotechnology Innovation Organization (BIO) today announced BIOEquality Agenda which aims to attack the systemic inequality, injustice and unfair treatment of women and communities of color through the positive force of biotechnology. Recognizing that gains from transformative science are not always shared equally, BIO is challenging the industry, and its partners, to find solutions for inequitable healthcare delivery, disp
Dr. McMurry-Heath raised these and other concerns in a
In response to attacks on Dr. Anthony Fauci’s credibility and character, BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement:
“As this global pandemic continues to wreak havoc, we must stand behind the scientists and researchers working tirelessly to eradicate this devastating disease. Nothing is more disheartening or disturbing than to see Dr. Anthony Fauci, a critical leader at a pivotal moment, maligned publicly and att
Today more than 20 leading biopharmaceutical companies announced the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as the threat of antimicrobial resistance, or AMR, continues to grow and claim more lives. In response to today’s launch of the fund, BIO issued the following statements celebrating the news:
&l
Tom DiLenge, President, Advocacy, Law and Public Policy, of the Biotechnology Innovation Organization (BIO), released the following statement regarding the prescription drug provisions in the Patient Protection and Affordable Care Enhancement Act (HR 1425):
“More than two-and-a-half million individuals across the country have been infected by the novel coronavirus and countless more have been personally impacted by this global pandemic. At a time when biopharmaceuti
The Senate Committee on Health, Education, Labor and Pensions, chaired by Senator Lamar Alexander, will hold an important hearing today to examine lessons learned from the current global health crisis to help make sure we are better prepared for the next pandemic. Public health expert and patient advocate, Dr. Julie Gerberding, will join the dis
BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement in advance of a congressional subcommittee hearing in the House Committee on Energy and Commerce on racial and ethnic disparities in Covid-19:
“The disproportionate impact of Covid-19 on communities of color is adding another painful dimension to this devastating disease, and it is time to take action. Today’s hearing is an important st
In the wake of tragic deaths and civil unrest, BIO’s President and CEO Dr. Michelle McMurry-Heath announced she will lead a panel discussion next week at BIO Digital with industry leaders on the state of race and equity within the biotechnology industry.
Following the announcement, Dr. McMurry-Heath shared her thoughts on events that have taken place in recent days:
“To say our country is at a crossroads would be an understatement. For the past few months, th
The Biotechnology Industry Organization (BIO) announced today it has joined the Coalition of Small Business Innovators (CSBI). CSBI is a national, non-partisan coalition of organizations dedicated to stimulating sustained, private investment in small, highly innovative companies focused on the development of new technologies.
BIO represents over 1,100 biotech innovators in all 50 states. Nationwide, these biotech firms employ 1.61 million Americans and support an additional 3.4 millio
The Biotechnology Industry Organization (BIO) invites biotechnology industry experts, policy leaders, analysts, academics and other thought leaders to submit proposals for breakout sessions at the 2012 BIO International Convention, the global event for biotechnology, to be held June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA.
Speakers and session moderator’s benefits abound at the BIO International Conventio